Molecular brain imaging in very early Alzheimer's disease

十二月 19, 2005

Brussels, 16 Dec 2005

The final workshop of a Fifth Framework Programme (FP5) concerted action on neuroreceptor imaging will take place in Copenhagen, Denmark, on 2 and 3 February.

'Neuroreceptor imaging in mild cognitive impairment' (NCI-MCI) ends in February 2006. Its objective has been to pose an early diagnosis and a prognosis for the development of Alzheimer's disease. In-vivo mapping of brain receptors in unaffected individuals, in patients with mild cognitive impairment, and in Alzheimer's disease have been compared.

The aim of the workshop is to give an overview of the results obtained, and to get feedback from scientists from the field.

Further information

CORDIS RTD-NEWS/© European Communities, 2005
Item source Previous Item Back to Titles Print Item

请先注册再继续

为何要注册?

  • 注册是免费的,而且十分便捷
  • 注册成功后,您每月可免费阅读3篇文章
  • 订阅我们的邮件
注册
Please 登录 or 注册 to read this article.